This is a federal contract award from the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The contract has a value of $1,244.44 and was awarded on December 4, 2024, with a completion date of December 24, 2024. The contract type is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing structure.
The contract is for the supply of OSTEOCEL PRO, a specialized spinal medical product, to support orthopedic, neurological, and reconstructive surgeries at Department of Defense (DoD) and Department of Veterans Affairs (VA) medical facilities. This contract award is not associated with any set-aside designation, indicating Nuvasive's strong market position in providing these types of specialized medical technologies.
Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, a for-profit medical device manufacturer that serves as the prime contractor. The contract is part of a larger $8 million Blanket Purchase Agreement (BPA) that Transplant Technology Inc. holds with the Defense Health Agency (DHA), which serves as an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle to provide a wide range of spinal medical devices and instruments to DoD and VA healthcare facilities nationwide.
Generated 3/5/25, 10:02 AM